Roche Invests $2.4 Billion in Autonomous AI Lab

Roche’s major investment in autonomous AI aims to enhance drug development efficiency, potentially accelerating medical breakthroughs.

Auto-scored: Low risk from AI capability advancement in medicine with substantive mitigation via improved clinical success.